Attributes | Values |
---|
rdf:type
| |
description
| - videnskabelig artikel (da)
- article científic (ca)
- article scientific (oc)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artigo científico (pt)
- artigo científico (pt-br)
- artikull shkencor (sq)
- artikulong pang-agham (tl)
- artykuł naukowy (pl)
- bilimsel makale (tr)
- scienca artikolo (eo)
- teaduslik artikkel (et)
- tieteellinen artikkeli (fi)
- tudományos cikk (hu)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- επιστημονικό άρθρο (el)
- научна статия (bg)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- სამეცნიერო სტატია (ka)
- บทความทางวิทยาศาสตร์ (th)
- artikel ilmiah (id)
- bài báo khoa học (vi)
- naučni članak (sr-el)
- мақолаи илмӣ (tg-cyrl)
- научни чланак (sr-ec)
- article scientifique (fr)
- artículu científicu espublizáu en 2013 (ast)
- 2013 nî lūn-bûn (nan)
- 2013年の論文 (ja)
- 2013年論文 (zh-hk)
- 2013年論文 (zh-tw)
- 2013年論文 (zh-hant)
- 2013年論文 (yue)
- 2013年論文 (zh-mo)
- 2013年论文 (zh)
- 2013年论文 (zh-cn)
- 2013年论文 (zh-sg)
- 2013年论文 (zh-hans)
- 2013年论文 (wuu)
- 2013年论文 (zh-my)
- 2013년 논문 (ko)
- artículo científico publicado en 2013 (es)
- наукова стаття, опублікована в червні 2013 (uk)
- مقالة علمية نشرت في 12 يونيو 2013 (ar)
- scientific article published on 12 June 2013 (en)
- scientific article published on 12 June 2013 (en-ca)
- scientific article published on 12 June 2013 (en-gb)
- 2013 թվականի հունիսի 12-ին հրատարակված գիտական հոդված (hy)
- ১২ জুন ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn)
|
publication date
| |
publication date
| |
language of work or name
| |
language of work or name
| |
author name string
| |
author name string
| - Jean-Marc Treluyer
- Deborah Hirt
- Dieudonné Ekoukou
- ANRS 135 PRIMEVA (Protease Inhibitor Monotherapy Evaluation) Study Group
- Eda Bui
- Jérome Le Chenadec
- Sandrine Delmas
|
rdfs:label
| - Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (en)
- Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (nl)
- Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (ast)
|
skos:prefLabel
| - Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (en)
- Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (nl)
- Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (ast)
|
name
| - Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (en)
- Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (nl)
- Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial (ast)
|
author
| |
author
| |